[Solved] Risks of psychedelics in addictions

The use of psychedelics in the treatment of addiction is a promising but also sensitive topic. Although therapy using substances such as psilocybin (from truffles) shows clear benefits, there are also risks you need to bear in mind — and it’s certainly not something you should do "on a whim".

At Triptherapie Psychedelics such as psilocybin are used in a professional setting, with a strong focus on preparation, support and integration. From information on psilocybin therapy in 2025 It appears that the drug can be effective in reducing cravings, such as those associated with alcohol or tobacco addiction. It works, amongst other things, via the serotonin system and promotes neuroplasticity, thereby helping to break deep-rooted patterns.

There are certainly risks, especially when psychedelics are used without supervision or in the wrong setting. According to the article on the Risks associated with magic mushrooms and magic truffles and the risks of a truffle ceremony, people with a predisposition to psychosis or severe mental health problems are at increased risk of negative experiences such as bad trips or even psychotic episodes. Furthermore, use in combination with certain medicines, such as antidepressants or antipsychotics, can lead to dangerous interactions.

On the forum Therapists and users share their experiences of psychedelic therapy for alcohol addiction. It appears to be effective when carried out under proper supervision, with a particular focus on addressing the underlying emotional pain or trauma that often lies at the root of addictions.

In summary: psychedelic therapy can help with addiction, but only if it’s done properly. Never try to do it on your own. It’s better to first the intake so that we can assess whether psychedelic therapy is suitable for your situation and whether there are any contraindications.

Using psychedelics as part of a guided treatment programme within a structured framework, such as that offered by Triptherapie, can be helpful. It is not simply a matter of administering an active substance; the entire setting plays a crucial role. In well-organised trip therapy, the process consists of several phases:

• Intake and screening: The client undergoes a detailed intake process during which contraindications, such as a history of mental health problems or other risks, are assessed. This is to determine whether the person is suitable for a psychedelic session.
• Preparation: Both the client and the therapist work together on the preparatory work, during which they discuss their intentions and expectations. Attention is paid to matters such as diet, sleep and mindset.
• The session itself: During the session, careful supervision is provided (by trip sitters and therapists, as shown in  triptherapie.nl) the client is at the centre of the process. The environment (for example, a quiet room with an eye mask and music) helps the individual to turn inwards and embrace the experience.
• Integration: Afterwards, intensive work is carried out to process the insights gained, so that they can be integrated into daily life in a healthy way.

Risks associated with psychedelics in the context of addiction treatment

Although there are promising research findings, there are also various risks that need to be carefully weighed up:

1. Individual variation and dose sensitivity:

   Psychedelic experiences can vary greatly. What has a therapeutic effect for one person may, for another, lead to an overwhelming experience or a "bad trip". The precise dosage is of crucial importance here, and errors in dosage or a sub-optimal setting can have a negative impact on the outcome.

2. Mental vulnerability:

   For people with a history of serious mental health conditions (such as bipolar disorder or a family history of psychotic symptoms), psychedelics may increase the risk of symptoms worsening. This is one of the reasons why a thorough assessment and screening are so important.

3. Incomplete scientific evidence:

   Despite growing research, psychedelic therapy is still not recognised as a standard treatment, and many applications remain at an experimental stage. This means that the long-term effects and optimal treatment protocols are not yet fully understood.

   Self-medication without professional supervision also carries significant risks, as the available clinical trials – such as the Triptherapie trial – integrate the patient’s experience and aftercare into a strictly controlled protocol.

4. Physical effects and acute reactions:

   Although physical risks are generally limited, some people may experience side effects such as nausea or palpitations, particularly if the experience is intense or poorly supervised.

Conclusion: Should you just go ahead and do it?

Based on the sources and insights discussed, it is not advisable to use psychedelics as a form of self-medication to overcome an addiction. The ‘trip therapy’ approach, as practised by organisations such as Triptherapie (cf. triptherapie.nl), emphasises the importance of a controlled and supervised setting. Professional support throughout all stages of therapy – from intake to reintegration – is crucial for:

• Minimising the risk of negative experiences.
• Dealing with any psychological distress.
• Optimising therapeutic outcomes.

Advice

If you are considering using psychedelics as part of addiction treatment, it is essential to:

• First, seek comprehensive medical and psychological advice.
• To opt for a structured and well-supervised programme, in which the client receives adequate support before, during and after the session.
• In summary, psychedelics – when used in a responsible and professional manner – can make a promising contribution to the treatment of addiction. However, self-experimentation without proper supervision is risky and is not recommended.

Here are some further additions to the rest:

Skipping life-threatening withdrawal symptoms
In cases of alcohol, benzodiazepine or opiate addiction, stopping suddenly without medical detoxification can be life-threatening. Psychedelics mask or disrupt the physical signs of withdrawal, which can lead a person to underestimate serious symptoms such as epileptic seizures or delirium tremens. A psychedelic session is only safe if the physical withdrawal phase is medically supervised.

Spiritual bypassing: insights without action
A powerful psychedelic experience can give the impression that the addiction has been "resolved", whilst daily habits, surroundings and coping mechanisms remain unchanged. If spiritual insights are used to avoid taking concrete therapeutic and behavioural steps, this can lead to disappointment and relapse.

Reinforcing feelings of shame and self-condemnation
During a trip, repressed emotions can surface. For people with a history of addiction, this can lead to overwhelming feelings of shame, guilt or worthlessness. Without proper aftercare and reintegration, this can actually reinforce the pattern of self-medication rather than breaking it.

Substitute behaviour and the pursuit of ecstasy
Although classic psychedelics are not physically addictive, the intense nature of the experience can lead vulnerable individuals to repeatedly seek out "the trip" as an escape from reality. There is a risk that this addiction may develop into an unhealthy dependence on psychedelic experiences, particularly when used without supervision.

Unrealistic expectations and the "miracle cure" mindset
Media coverage of psychedelics sometimes creates the impression of a quick, almost magical cure. If a session does not lead immediately to abstinence, this can be demotivating and undermine confidence in other treatment methods. Psychedelic therapy is not a standard replacement but part of a broader, long-term recovery process.